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G e s t a t i o n a l  t r o p h o b l a s t i c  
disease(GTD),constitutes a spectrum of tumors 
and tumor-like conditions characterized by 
abnormal proliferation of pregnancy associated 
trophoblastic tissues of varying propensities for 
1 - 3
invasion and spread.  They include 
hydatidiform mole (HM), invasive mole, 
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ABSTRACT
Background: Hydatidiform mole is a benign tumour of the trophoblast tissue and a relatively 
common gynaecological emergency. It could resolve spontaneously following evacuation, 
however 9-20% of patients with complete hydatidiform mole go on to have gestational trophoblast 
neoplasia. It is potentially curable once the correct diagnosis is made and the treatment is 
commenced early.
Objective: This study is aimed at determining the incidence of hydatidiform mole in Aminu Kano 
Teaching Hospital (AKTH), its age distribution, complication and outcome
Study Design: A retrospective review of case of hydatidiform mole managed in Aminu Kano 
st st
Teaching Hospital, Kano between 1  January, 2009 and 31  December, 2012. Patients' information 
were obtained from gynaecology ward admission record book, and patient files were retrieved from 
the record department and data analysed using SPSS version 11.
Result: 87 cases of hydatidiform mole were managed during the study period. 57 cases were 
retrieved and analysed with a retrieval rate of 66%. The mean age of the  was 30.42(SD7.8). The 
incidence of hydatidiform mole in this study is 1 in 260 deliveries. The mean parity was 3.68 (SD 
2.69). The commonest presentation was vaginal bleeding (47.4%). Half of the patients (52.6%) had 
preevacuation serum beta HCG and only 21.1% had beta HCG estimation at six weeks post 
evacuation. The only complication was severe vaginal bleeding requiring blood transfusion 
(10.5%). 10.5% of the cases progressed to choriocarcinoma.
Conclusion: Hydatidiform mole remains a common premalignant lesion of the female genital tract. 
Early diagnosis and strict follow ups with relevant investigation is necessary for early detection of 
progression to choriocarcinoma. 
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INTRODUCTON 
placental-site trophoblastic tumor, and 
2,4
choriocarcinoma.  Hydatidiform Mole is the 
4,5,
commonest GTD.
It could resolve spontaneously following 
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evacuation, however 9-20% of patients with 
complete hydatidiform mole go on to have 
6gestational trophoblast neoplasia.
Hydatidiform mole is unique among human 
tumours in its acute oncogenesis and the 
extremely short interval between the 
7development of the disease and its diagnosis.  
Sonographic diagnosis and hormonal follow up 
6,7are crucial in its management.
The incidence of HM varies greatly throughout 
the world ranging from 0.5 to 8.3 per 1000 live 
births and occurs more frequently in Asia 
1,2,4 
compared with Western countries. Studies 
from various parts of Nigeria have reported 
incidence ranging from 1.7 to 6 per 1000 
1,5,7
births.  HM presents with amenorrhoea, 
vaginal bleeding and spontaneous passage of 
grape-like vesicles, high serum and urinary â 
human chorionic gonadotrophin (âHCG) levels. 
There may also be hyperemesis gravidarum, 
doughy uterus, inappropriate uterine size, 
bilateral theca lutein cyst and rarely, features of 
thyrotoxicosis and pre-eclampsia in the first half 
5,8
of pregnancy.
The disease could also present as spontaneous 
abortion which is one of the commonest 
5-8gynaecological emergencies. There have been 
few reports on HM in our environment and and 
no study on its incidence has been carried out in 
Kano. This study was therefore carried out to 
determine the incidence of hydatidiform mole, 
the clinical features and management outcome 
at the Aminu Kano Teaching Hospital, Kano, 
Nigeria.
METHODOLOGY
A retrospective review of case of hydatidiform 
mole managed in Aminu Kano Teaching 
st
Hospital, Kano between 1  January, 2009 and 
st31  December, 2012. Patients' information was 
obtained from gynaecology ward admission 
record book, and patient files were retrieved 
from the record department and data obtained 
was analysed using SPSS version 11.
RESULTS
Eighty seven (87) cases of hydatidiform mole 
were managed during the study period. 57 cases 
were retrieved and analysed with a retrieval rate 
of 66%. The mean age of the patient was 
30.42(SD 7.8). In the study period we had a total 
of 22,581 deliveries, given an incidence of 
hydatidiform mole in this study to be 1 in 260 (4 
in 1000) deliveries. Table 1, shows age 
distribution of patients with hydatidiform mole 
with age range of 20-49yrs.The mean age of the 
patient was 30.42(SD 7.8).The mean parity was 
3.68 (SD 2.69). The commonest presentation 
was vaginal bleeding (47.4%). Half of the 
patients (52.6%) had preevacuation serum beta 
HCG and only 21.1% had beta HCG estimation 
at six weeks post evacuation. The only 
complication was severe vaginal bleeding 
requiring blood transfusion (10.5%). 10.5% of 
the cases progressed to choriocarcinoma.
Age Distribution













30-34 15 26.3  
35-39 12 21.0  






Mean age=30.42 yrs ± 7.8
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Post Evacuation BHCG
DISCUSSION
The incidence of hydatidiform mole of 1:260 
deliveries in this study is higher than 1:1000 
6
pregnancies in the united states of America,  
5
1:357 reported in Jos, north central Nigeria,  and 
1:588 pregnancies reported at Ile-Ife ,south west 
5
Nigeria.  but lower than the incidence of 1:120 
2,6
reported in Taiwan. It is also lower than 1:172 
and 1:184 deliveries reported from Ibadan and 
5
Lagos –both in Nigeria.  The reason for this 
geographical variation is unknown but the fact 
that these are hospital-based studies in tertiary 
referral centers in an environment with varying 
degrees of hospital utilization may be 
contributory.
Most of the patients (84%) were between the 
ages of 20-39 years. This was similar to the 
finding in Calabar in the eastern part of 
9
Nigeria. Many authors had agreed that the risk of 
hydatidiform mole is higher in pregnant woman 
who are under 20 years and above 35 years of 
age, with a progressive increase after 40 years 
2,3,11
.  This is however not the case in this study, as 
5.3% and 31.6% of the patients were less than 
20years and greater than 35years of age 
respectively, which is similar to the report from 
5,7
Jos and Ilorin north central Nigeria.  The reason 
for this geographical variation in age at 
presentation may be because most of our patients 
are illiterates and may not know their actual age. 
Mean age at presentation here was 30.42years 
which is similar to the finding in Ilorin and 
7,12Maiduguri.
The most common complication was severe 
vaginal bleeding requiring blood tra      nsfusion 
(10.5%). This was also reported in Lagos 
10
Western Nigeria.
Suction curettage was the method of treatment in 
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21.1% had BHCG done at 6 weeks follow up. 10.5% (2 cases)
progressed to have choriocarcinoma
72
Trop J Obstet Gynaecol, 31 (2), August 2014
because it allows for rapid evacuation of the 
uterus irrespective of the uterine size with 
1,3 minimal blood loss. It also provides specimen 
for histological assessment of the products of 
conception, reduces the danger of uterine 
perforation, minimizes injury to the blood 
vessels and therefore reduces the chance of 
5,7trophoblastic tissue embolization. It is 
associated with a low risk of chemotherapy 
1,6,7usage for gestational malignancy.  Because 
the RhD antigen is present in trophoblasts, 
patients with an Rh-negative blood type should 
receive Rh 
About 20% of patients with complete 
hydatidiform mole would develop malignant 
6,12sequelae.  In this study, approximately 10.5% 
of the cases progressed to develop 
choriocarcinoma, this is similar to  9.4% 
11reported in Onitsha South eastern Nigeria.  No 
maternal mortality was recorded in this study. 
None of the patients in this study completed the 
recommended period of follow up. This was 
5,7,10similar to the findings in other studies.
CONCLUSION
Hydatidiform mole remains a common 
gynecological emergency in AKTH, Kano north 
west Nigeria. Age at presentation varies from 
one geographical location to the other, and 
bleeding per vaginam often necessitating blood 
transfusion is a common complication. Early 
diagnosis and strict follow up of cases of 
hydatidiform mole with relevant investigations 
is necessary for early detection of progression to 
choriocarcinoma. It is therefore recommended 
that patients with hydatidiform mole should be 
adequately counseled on strict adherence to the 
recommended follow up period for early 
detection of progression to choriocarcinoma. 
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